Novel coumarin modified GLP-1 derivatives with enhanced plasma stability and prolongedin vivoglucose-lowering ability
Author:
Affiliation:
1. Center of Drug Discovery; State Key Laboratory of Natural Medicines; China Pharmaceutical University; Nanjing China
2. Division of Antitumor Pharmacology; Shanghai Institute of Materia Medica; Chinese Academy of Sciences; Shanghai China
Funder
the National Natural Science Foundation of China
the Natural Science Foundation of Jiangsu Province
Publisher
Wiley
Subject
Pharmacology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/bph.12843/fullpdf
Reference43 articles.
1. GLP-1 receptor agonists and DPP-4 inhibitors in the treatment of type 2 diabetes;Ahren;Horm Metab Res,2005
2. The Concise Guide to PHARMACOLOGY 2013/14: G Protein-Coupled Receptors;Alexander;Br J Pharmacol,2013a
3. The Concise Guide to PHARMACOLOGY 2013/14: Enzymes;Alexander;Br J Pharmacol,2013b
4. Efficacy and safety of incretin therapy in type 2 diabetes;Amori;JAMA,2007
5. Biology of incretins: GLP-1 and GIP;Baggio;Gastroenterology,2007
Cited by 45 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Synthesis, physicochemical characterization, and investigation of anti-inflammatory activity of water-soluble PEGylated 1,2,4-Triazoles;Bioorganic Chemistry;2024-06
2. An imbalanced GLP-1R/GIPR co-agonist peptide with a site-specific N-terminal PEGylation to maximize metabolic benefits;iScience;2024-04
3. Exploring a Synergistic Approach: Dual GLP-1 Agonist Combined with Degludec Basal Insulin for Early Type 1 Diabetes Treatment and its Impact on Albumin-Insulin Producing Cells Expression;Advanced Pharmaceutical Bulletin;2024-03-18
4. The gut odorant receptor and taste receptor make sense of dietary components: A focus on gut hormone secretion;Critical Reviews in Food Science and Nutrition;2023-02-13
5. Identification of potential drug candidates as TGR5 agonist to combat type II diabetes using in silico docking and molecular dynamics simulation studies;Journal of Biomolecular Structure and Dynamics;2023-02-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3